Prognostic values of baseline 18F-FDG PET/CT in patients with peripheral T-cell lymphoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025526

Enrollment

Unknown

Registered

2019-08-31

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral T-cell lymphoma

Interventions

Gold Standard:hematological test

Index test:18F-FDG PET/CT

Eligibility

Sex/Gender

All

Age

15 Years to 88 Years

Inclusion criteria

Inclusion criteria: (1) histopathology confirmed as PTCL (PTCL-NOS, AITL or ALCL ALK-); (2) availability of digital image data for analysis.

Exclusion criteria

Exclusion criteria: Patients with ALCL ALK+ were excluded.

Design outcomes

Primary

Measure	Time frame
SUVmax;MTV;TLG;	—

Countries

China

Contacts

Public ContactShengming Deng

dshming@163.com+86 18506291758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026